📰 Psychedelics News

Curated updates on microdosing, research, policy, and community.

Filters

2026-02-06 The Microdose (Berkeley)

Legislative updates in Mississippi, West Virginia, Oregon, and New Hampshire; Fast-tracked federal approval of Compass's synthetic psilocybin was vetoed; Federal bill proposes VA study psychedelics

Plus: Definium (formerly MindMed) hit with “trade secret” lawsuit; and an analysis of ibogaine experiences

2026-02-06 The Psychedelic Blog (Substack)

Why the Brain Keeps Inventing Entities

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.

2026-02-06 DoubleBlind Magazine

Veterans Caught Between Policy Paralysis and Controversy in DC

As Congress weighs new psychedelic bills, veterans remain caught between promise, policy, and unresolved ethical concerns. [...] Read More... The post Veterans Caught Between Policy Paralysis and Controversy in DC app...

2026-02-06 Psychedelic Alpha

Pα+ Psychedelic Bulletin #219: Trump Admin. Vetoed Compass Priority Voucher; Ibogaine in Focus; Definium Sued by Former Vendor; Psychedelics Feature in Epstein Files

Trump Administration Vetoed Compass Pathways Priority Voucher • Ibogaine in Focus (State Bills Progress, Safety and Regulation, State Programs and Global Supply, Drug Development Remains Early-Stage, DemeRx Shares P...

2026-02-05 MAPS

In a Defining Election Year, MAPS Releases Policy Guidebook to Shape the Future of Psychedelic Reform

Washington, DC; February 4, 2026 — With the United States in a pivotal election year, the Multidisciplinary Association for Psychedelic Studies (MAPS) released its Policy Guidebook, a robust resource for psychedelic p...

Policy
2026-02-05 Psychedelic Alpha

Center for MINDS: Bruce Damer on Why We Need Psychedelic-Catalysed Innovation

Psychedelic Alpha’s Charles Bliss speaks with astrobiologist Dr. Bruce Damer about the Center for MINDS' mission and how it is picking up the “abandoned thread” of research into psychedelics as catalysers of creativit...

2026-02-05 Chemical Collective

Le LSA : la version naturelle du LSD ?

Nuit compare les expériences de LSA issues de deux sources de semences, contextualisées par l’histoire et la science, dans le but de présenter une vision équilibrée des effets variables, des incertitudes, des risques ...

2026-02-05 Australian Psychedelic Society

APS Survey

 · Help Us Grow Together The Australian Psychedelic Society (APS) is built on community connection, shared knowledge, and a strong commitment to harm reduction and safety. We want to make sure what we offer g...

2026-02-05 Lucid News

Legislation, Industry, and the Future of Psilocybin for PTSD 

The FDA acceptance of Compass Pathway’s Investigational New Drug Application for their COMP360 compound as a possible therapy for PTSD introduces a new area of possible therapies using psilocybin. The post Legislati...

Research Policy
2026-02-04 DoubleBlind Magazine

Neuroscientist Uses VR to Study Why Psychedelics Make Us Trip

Virtual reality offers a new lens on the science behind the psychedelic experience. [...] Read More... The post Neuroscientist Uses VR to Study Why Psychedelics Make Us Trip appeared first on DoubleBlind Mag.

2026-02-03 Chemical Collective

Can Psychedelics Help Mend Broken and Ailing Brains?

Stroke, traumatic brain injury, and neurodegenerative diseases are leading, interconnected causes of global disability and economic burden with limited effective treatments. Sam Gandy highlights the potential of psych...

2026-02-02 Psychedelics Today

Patient Safety After a Death: What Transparency Can and Cannot Do

A Tragedy at an Ibogaine Clinic — and the Policy Failure Behind It A patient death in any care setting is a tragedy. In this case, it involves ibogaine, a medically complex intervention that sits outside regulated med...

2026-02-02 Psychedelic Alpha

The Psychedelic News Feed: January 26 – Febraury 1, 2026

Your one-stop digest for the latest coverage of psychedelics business, policy, research and beyond, for the week commencing January 26, 2026.

2026-02-02 The Microdose (Berkeley)

Psychedelic narcissism: 5 Questions for psychotherapy researcher Henrik Jungaberle

Jungaberle discusses how the drugs famous for ego-death can also reinforce the ego.

2026-02-02 MAPS

MAPS and Columbia University Partner on First-of-its-Kind Study of MDMA-Assisted Couples Therapy

February 2, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announces a formal research partnership with Columbia University to study how practitioners are facilitating MDMA-assisted couples th...

Research